Home / Our company / Our commitment to patients
Our longstanding commitment to patients has led us to reimagine our patient-focused ways of working, as we embed it across every aspect of our company to deliver the healthcare experience and outcomes people care about most so they can enjoy fulfilling lives.
Patients as people first
We recognise that patients are people first and should be at the centre of everything we do in specific and measurable ways, from discovery science through clinical trials to prevention, awareness, diagnosis, treatment and post-treatment. We are evolving our ways of working to address the current and future needs of patients, so we are better able to help answer those needs and deliver for our company. We are working with partners to help create integrated ‘healthcare ecosystems’ that bring benefits and support for the whole of the patient experience.
We’ve made strong headway in fostering a patient-immersed culture, arming our colleagues with core resources and guidance materials that aligns all of us clearly around our vision and purpose for patient centricity. We have a strong foundation deeply rooted in seeing patients as people first so that we can continue to show up for them in specific and measurable ways.
Here are some of our key commitments to patients and patient groups.
Patient engagement
- Working closely with patients and patient groups to understand how disease impacts daily living, use of support mechanisms, and how to support lasting behavioural change.
- Expanding our networks and interactions, directly through our clinical trials and indirectly through our relationships with healthcare professionals and patient groups, to enrich our understanding of the healthcare environment and needs.
Attentive listening
- Listening to patients during the research& development process to understand their needs and discover barriers to better diagnose and design the right treatments.
Leveraging technology
- Using technology to develop end-to-end evidence capabilities that ensure more patient insights are considered while embracing new technologies such as digital sensors, integrated apps, connected devices and artificial intelligence to help people to take control of their health.
Active co-creation
- Continuing dialogue after a new medicine launch to evolve our approach, improve the services around our medicines and deliver solutions that improve lives from post-treatment to wellness.
Targeted innovation
- Using real world evidence to show how our medicines, services and business models bring value to those who rely on them.
- Further developing our genomics research to ensure that the right medicines reach the right patients at the right time.
Health innovation hubs
Our Health Innovation Hubs put us at the centre of interaction among patients, medicine, technology, healthcare professionals and policy makers to reimagine how we can improve patient outcomes through:
Better public-private partnerships based on a shared innovation agenda
Co-creation with start-up companies and technology partners
Innovation to improve the entire patient experience with whole disease solutions
